Literature DB >> 20236427

Prevalence of integrons and a new dfrA17 variant in Gram-negative bacilli which cause community-acquired infections.

Cemal Sandalli1, Celal Kurtulus Buruk, Metin Sancaktar, Osman Birol Ozgumus.   

Abstract

A hundred and eleven Gram-negative bacilli from community-acquired infections were characterized by antimicrobial susceptibility testing, screened for class 1 and 2 integrons, and statistically evaluated for the association between antibiotic profile and the presence of integrons. The frequency with which integrons were harbored was 28.8%. Three E. coli strains contained a dfrA17 variant inserted in a class 1 integron. Results of PFGE indicated that some E. coli strains carrying integrons were clonally related. Carriage of gene cassettes was significantly associated with resistance to certain antibiotics (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236427     DOI: 10.1111/j.1348-0421.2010.00197.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  First report on class 1 integrons and Trimethoprim-resistance genes from dfrA group in uropathogenic E. coli (UPEC) from the Aleppo area in Syria.

Authors:  Bodour Al-Assil; Maysa Mahfoud; Abdul Rezzak Hamzeh
Journal:  Mob Genet Elements       Date:  2013-06-03

2.  Capturing the Resistome: a Targeted Capture Method To Reveal Antibiotic Resistance Determinants in Metagenomes.

Authors:  Allison K Guitor; Amogelang R Raphenya; Jennifer Klunk; Melanie Kuch; Brian Alcock; Michael G Surette; Andrew G McArthur; Hendrik N Poinar; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

3.  Antimicrobial resistance patterns and integron carriage of Escherichia coli isolates causing community-acquired infections in Turkey.

Authors:  Aysegul Copur-Cicek; Osman Birol Ozgumus; Aysegul Saral; Cemal Sandalli
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.